Nihon Kohden Lifts Profit Outlook as Global Network Expands Despite Modest Sales Growth

Nihon Kohden Corporation ( (JP:6849) ) just unveiled an announcement.

Nihon Kohden reported consolidated net sales of ¥235.1 billion for the fiscal year ended March 31, 2026, up 4.3% year on year, while operating income fell 9.5% to ¥18.7 billion and income attributable to owners of parent edged up 2.9% to ¥14.5 billion. Profitability metrics such as operating margin and return on equity remained modest, but comprehensive income grew strongly and cash flow from operating activities was solid, supporting a slight increase in annual dividends.

The company strengthened its global footprint by adding three consolidated subsidiaries, including entities in India and Arabia, while removing two others, reflecting a portfolio realignment toward growth regions and advanced technologies. For the year ending March 31, 2027, Nihon Kohden forecasts a slight decline in sales but double‑digit growth in operating and ordinary income, as well as higher earnings per share and continued dividend payouts, signaling a focus on improving profitability despite a cautious revenue outlook.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1800.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

More about Nihon Kohden Corporation

Nihon Kohden Corporation, listed on the Prime Market of the Tokyo Stock Exchange, operates in the medical device industry, supplying monitoring, diagnostic and related hospital equipment. The company serves healthcare institutions in Japan and overseas, with a strategy that includes regional hubs such as India and the Middle East to support global expansion.

Average Trading Volume: 580,338

Technical Sentiment Signal: Sell

Current Market Cap: Yen239B

See more insights into 6849 stock on TipRanks’ Stock Analysis page.